Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-26

Clinical Trial Update: Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD) [EARLY_Phase 1]

View source ↗

Summary

This update summarizes the results of an early-phase Phase 1 study evaluating chitosan chewing gum as a phosphate binder in patients with chronic kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chitosan chewing gum (chitosan chewing gum)

Snippet

Sponsor: Denver Nephrologists, P.C. | Conditions: Chronic Kidney Disease | EARLY_Phase 1 | Status: COMPLETED